Efficacy of EC-MPS compared to MMF in Chinese patients as measured by the incidence of biopsy proven acute rejection, graft loss, or death within six months of treatment in de novo renal transplant recipients. [clinicaltrials_resource:7f4df3bc828ff46ed66cb1abedabc892]

Efficacy of EC-MPS compared to MMF in Chinese patients as measured by the incidence of biopsy proven acute rejection, graft loss, or death within six months of treatment in de novo renal transplant recipients. [clinicaltrials_resource:7f4df3bc828ff46ed66cb1abedabc892]